GlassScriptPhysician profile
Miguel R Silva
NPI 1942386412
$4,325.30
in general payments reported to CMS, 2019-2025
6 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2021: $28.94 · 2022: $18.20 · 2023: $349 · 2024: $2,452 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,703 · Food and Beverage: $1,348 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,702.71 |
| Food and Beverage | $1,348.06 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,373.00 | 2023-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $555.52 | 2019-2024 | Echelon Circular, Surgicel Nu-Knit, Echelon Endopath |
| Medtronic, INC. | $173.13 | 2023-2024 | Signia, Endo Gia Ultra |
| W. L. Gore & Associates, INC. | $143.27 | 2023 | Seamguard |
| Davol INC. | $49.06 | 2024-2025 | Phasix Mesh |
| Baxter Healthcare | $31.32 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.